Russia to use 40,000 people to test vaccine against Covid-19

More than 20 countries have placed purchase orders for 1 billion doses of the vaccine.

Moscow. - Russia announced this Thursday the beginning in the next week of clinical trials with more than 40,000 people of its vaccine against Covid-19, announced on August 11 and perceived with skepticism by the international community.

Russia announced this Thursday the beginning in the next week of clinical trials with more than 40,000 people of its vaccine against Covid-19, announced on August 11 and perceived with skepticism by the international community.
More than 20 countries have placed purchase orders for 1 billion doses of the vaccine
‘Next week (...), a clinical study on the efficacy (...) and safety of the Sputnik V vaccine will begin in Russia,’ said the Russian sovereign wealth fund, associated in its development, specifying that ‘more 40,000 people will participate in the study in more than 45 medical centers.’
The official website dedicated to the vaccine, meanwhile, had announced that ‘phase 3 of the clinical trials, with more than 2,000 people’ in various countries had started on August 12.
Questioned by the AFP regarding these tests, the press service of the sovereign wealth fund pointed out: ‘there is no phase 3 in Russian law.’
‘From a legal point of view, these are studies that are done after the vaccine was registered’ on August 11, he explained, adding that they can be considered an ‘equivalent to phase 3.’
The director of the sovereign wealth fund, Kirill Dmitriev, indicated this Thursday during an online briefing that the vaccination of ‘risk groups’, which includes health personnel, will also begin next week on a voluntary basis.
More than 20 countries have placed purchase orders for 1 billion doses of the vaccine, he added. He also said that Russia has agreed to produce the vaccine in five countries.
Dmitriev also indicated that ‘mass vaccinations in Russia are planned to begin in October’, while deliveries of vaccines abroad are scheduled to begin in November or December. A delegation from the Saudi Arabian Ministry of Health is expected in Moscow next week, he added.
Sputnik V, a name that refers to the first artificial satellite in history, is viewed with skepticism in most of the world, especially due to the lack of a final phase of tests at the time of being announced.
‘We have seen a significant change in the tone used by the WHO (World Health Organization). At first, in fact, they did not have enough information about the Russian vaccine, now official information has been sent to them and they will evaluate it,’ he continued. Dmitriev.
‘We see no obstacle to individual regulators approving the vaccine without WHO having done so,’ he added.

Share:

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

ad

Popular News

Recent Posts